Search Results - "CHINOL, Marco"
-
1
State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging
Published in Current radiopharmaceuticals (01-01-2019)“…Neuroendocrine Tumors (NETs) are relatively rare tumors, mainly originating from the digestive system, that tend to grow slowly and are often diagnosed when…”
Get more information
Journal Article -
2
Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience
Published in Current radiopharmaceuticals (01-01-2016)“…Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin analogues has shown encouraging results in various somatostatin receptor positive…”
Get more information
Journal Article -
3
PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS
Published in Journal of cancer & allied specialties (31-12-2016)“…The radionuclide therapies for solid and liquid malignancies are emerging field nowadays. The targeted radionuclide therapies have been in use since 1945. In…”
Get full text
Journal Article -
4
Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer
Published in Clinical cancer research (15-09-2007)“…Purpose: In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of the Intraoperative…”
Get full text
Journal Article Conference Proceeding -
5
Low and High Tenascin-Expressing Tumors Are Efficiently Targeted by ST2146 Monoclonal Antibody
Published in Clinical cancer research (01-04-2006)“…ST2146biot is a biotinylated anti-tenascin monoclonal antibody (mAb) to be used for Pretargeted Antibody Guided Radioimmunotherapy (PAGRIT) of solid tumors. In…”
Get full text
Journal Article -
6
Blaine T. Smith and Kara D. Weatherman (eds): Diagnostic Imaging for Pharmacists
Published in European journal of nuclear medicine and molecular imaging (01-07-2012)Get full text
Journal Article -
7
-
8
Yttrium-labelled peptides for therapy of NET
Published in European journal of nuclear medicine and molecular imaging (01-02-2012)“…Peptide receptor radionuclide therapy (PRRT) consists in the systemic administration of a synthetic peptide, labelled with a suitable beta-emitting…”
Get full text
Journal Article -
9
Author Correction: A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions
Published in Scientific reports (10-03-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
10
A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions
Published in Scientific reports (04-04-2019)“…This paper describes a new nuclear imaging agent, 2-(4-isothiocyanatobenzyl)−1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid of human albumin (HAC),…”
Get full text
Journal Article -
11
Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
Published in The Journal of nuclear medicine (1978) (01-01-2005)“…A new treatment modality for inoperable or metastasized gastroenteropancreatic tumors is the use of radiolabeled somatostatin analogs. Initial studies with…”
Get full text
Journal Article -
12
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids
Published in Chemical engineering and processing (01-12-2017)“…[Display omitted] •Cyclooctapeptides dicarba-analogues of Somatostatin containing d or l-allylglycine.•MW-driven on-resin Ring Closing Metathesis (RCM) of…”
Get full text
Journal Article -
13
Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers
Published in Organic & biomolecular chemistry (07-04-2015)“…Chemical modifications of the biotin carrier in pretargeted avidin–biotin radionuclide therapy may be of paramount importance for tuning the amount of the…”
Get more information
Journal Article -
14
Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group
Published in Seminars in nuclear medicine (01-04-2002)“…High concentrations of subtype 2 somatostatin tumor receptors (sst(2)) are expressed in numerous tumors, enabling primary and metastatic masses to be localized…”
Get full text
Journal Article -
15
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients
Published in Blood (16-11-2012)“…Abstract 4876 Here we report one single centre experience with 90Y Ibritumomab tiuxetan in order to investigate the incidence of treatment-related…”
Get full text
Journal Article -
16
Yttrium-labelled peptides for therapy of NETtherapy
Published in European journal of nuclear medicine and molecular imaging (01-02-2012)“…Issue Title: Radiolabelled Peptides for Diagnosis and Therapy Peptide receptor radionuclide therapy (PRRT) consists in the systemic administration of a…”
Get full text
Journal Article -
17
Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safety
Published in European journal of nuclear medicine and molecular imaging (01-11-2006)“…The widespread interest in (90)Y internal radionuclide treatments has drawn attention to the issue of radiation protection for staff. Our aim in this study was…”
Get full text
Journal Article -
18
Biotin Derivatives Carrying Two Chelating DOTA Units. Synthesis, in Vitro Evaluation of Biotinidases Resistance, Avidin Binding, and Radiolabeling Tests
Published in Journal of medicinal chemistry (14-01-2010)“…The synthesis of four biotin derivatives carrying two DOTA moieties for each ligand (BisDOTA set) is reported, for increasing radiation/dose ratio and…”
Get full text
Journal Article -
19
Production and quality control of [90Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 syntheses
Published in Nuclear medicine communications (01-03-2013)“…The aim of this paper was to describe the optimized labeling protocol and quality control measures used in the production of [Y]DOTATOC, starting from three…”
Get full text
Journal Article -
20
Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT)
Published in European journal of nuclear medicine and molecular imaging (01-01-2007)“…A novel biotin-DOTA conjugate (r-BHD: reduced biotinamidohexylamine-DOTA) was investigated in order to provide an efficient pretargeted antibody-guided…”
Get full text
Journal Article